| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99199 |
Unlisted special service, procedure or report |
862,159 |
454,396 |
$4.92M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
98,114 |
71,254 |
$4.85M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
42,747 |
31,854 |
$1.75M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
11,086 |
8,355 |
$720K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,812 |
3,722 |
$470K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16,557 |
11,428 |
$461K |
| 99215 |
Prolong outpt/office vis |
3,203 |
2,379 |
$211K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14,471 |
6,034 |
$174K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,709 |
1,438 |
$108K |
| 87428 |
|
2,174 |
1,419 |
$95K |
| 80305 |
|
15,037 |
11,627 |
$91K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
691 |
645 |
$80K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
855 |
640 |
$73K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,056 |
942 |
$73K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,705 |
1,144 |
$72K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
711 |
553 |
$55K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,773 |
3,824 |
$53K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
590 |
454 |
$50K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,385 |
1,073 |
$46K |
| 99490 |
Ccm add 20min |
3,185 |
2,821 |
$37K |
| 96127 |
|
9,542 |
7,323 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
981 |
696 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,525 |
1,780 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,761 |
3,672 |
$22K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
188 |
157 |
$17K |
| 82947 |
|
5,345 |
4,061 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,227 |
927 |
$9K |
| 81003 |
|
6,155 |
4,718 |
$9K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
4,123 |
3,293 |
$7K |
| 99406 |
|
769 |
543 |
$5K |
| 92551 |
|
1,539 |
1,193 |
$5K |
| 99205 |
Prolong outpt/office vis |
30 |
24 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
148 |
142 |
$4K |
| 87807 |
|
333 |
236 |
$4K |
| D0145 |
Oral evaluation for a patient under three years of age |
160 |
97 |
$3K |
| 80061 |
Lipid panel |
379 |
289 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
74 |
65 |
$3K |
| 20610 |
|
216 |
111 |
$3K |
| 99173 |
|
1,728 |
1,352 |
$2K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
31 |
30 |
$2K |
| 86328 |
|
126 |
76 |
$2K |
| D1206 |
Topical application of fluoride varnish |
160 |
97 |
$2K |
| 99386 |
|
17 |
12 |
$1K |
| 0011A |
|
46 |
24 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
88 |
70 |
$1K |
| 90670 |
|
178 |
124 |
$985.01 |
| 93000 |
|
134 |
109 |
$826.62 |
| 0012A |
|
13 |
12 |
$780.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
130 |
99 |
$635.79 |
| 81025 |
|
93 |
82 |
$634.06 |
| 0072A |
|
13 |
12 |
$549.58 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
62 |
39 |
$546.82 |
| 90674 |
|
192 |
132 |
$522.56 |
| 90461 |
|
86 |
65 |
$514.67 |
| 90715 |
|
25 |
15 |
$297.78 |
| 90677 |
|
70 |
70 |
$268.63 |
| 82570 |
|
90 |
79 |
$263.31 |
| 82044 |
|
91 |
80 |
$169.47 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
129 |
82 |
$115.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
183 |
154 |
$91.88 |
| 99401 |
|
20 |
13 |
$84.00 |
| 3044F |
|
1,110 |
882 |
$80.00 |
| 90633 |
|
52 |
41 |
$70.01 |
| 82962 |
|
82 |
77 |
$50.05 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
16 |
$28.80 |
| 90688 |
|
120 |
84 |
$15.47 |
| 99497 |
|
13 |
12 |
$13.37 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
71 |
53 |
$11.52 |
| 1111F |
|
1,468 |
1,230 |
$1.47 |
| 3074F |
|
61,561 |
48,160 |
$0.15 |
| 3078F |
|
49,896 |
39,544 |
$0.12 |
| 1160F |
|
64,567 |
47,443 |
$0.06 |
| 1159F |
|
62,164 |
45,727 |
$0.05 |
| 3079F |
|
21,720 |
17,289 |
$0.04 |
| 3075F |
|
9,414 |
7,593 |
$0.02 |
| 3077F |
|
1,799 |
1,451 |
$0.01 |
| 1126F |
|
6,244 |
4,858 |
$0.01 |
| 3080F |
|
2,139 |
1,702 |
$0.01 |
| 3725F |
|
22,774 |
18,010 |
$0.00 |
| 0521F |
|
1,482 |
1,196 |
$0.00 |
| 90648 |
|
22 |
13 |
$0.00 |
| 90649 |
|
16 |
14 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
34 |
28 |
$0.00 |
| 90710 |
|
14 |
12 |
$0.00 |
| 3062F |
|
22 |
15 |
$0.00 |
| 1036F |
|
46,493 |
34,833 |
$0.00 |
| 3008F |
|
27,035 |
20,757 |
$0.00 |
| 1125F |
|
2,818 |
2,312 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
95 |
88 |
$0.00 |
| 1034F |
|
11,914 |
8,975 |
$0.00 |
| 94760 |
|
68 |
51 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
164 |
122 |
$0.00 |
| 3061F |
|
577 |
486 |
$0.00 |
| 1101F |
|
922 |
782 |
$0.00 |
| 90680 |
|
37 |
37 |
$0.00 |
| 91301 |
|
52 |
37 |
$0.00 |
| 3060F |
|
44 |
36 |
$0.00 |
| 90656 |
|
37 |
34 |
$0.00 |
| 90696 |
|
14 |
12 |
$0.00 |